- Home
- ALOT vs GNTA Comparison
ALOT vs GNTA Comparison
Compare ALOT & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALOT
- GNTA
- Stock Information
- Founded
- ALOT 1969
- GNTA 2014
- Country
- ALOT United States
- GNTA Italy
- Employees
- ALOT N/A
- GNTA N/A
- Industry
- ALOT Computer peripheral equipment
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALOT Technology
- GNTA Health Care
- Exchange
- ALOT Nasdaq
- GNTA Nasdaq
- Market Cap
- ALOT 69.2M
- GNTA 70.8M
- IPO Year
- ALOT N/A
- GNTA 2021
- Fundamental
- Price
- ALOT $9.37
- GNTA $4.49
- Analyst Decision
- ALOT
- GNTA Strong Buy
- Analyst Count
- ALOT 0
- GNTA 1
- Target Price
- ALOT N/A
- GNTA $25.00
- AVG Volume (30 Days)
- ALOT 14.7K
- GNTA 2.7K
- Earning Date
- ALOT 06-05-2025
- GNTA 01-01-0001
- Dividend Yield
- ALOT N/A
- GNTA N/A
- EPS Growth
- ALOT N/A
- GNTA N/A
- EPS
- ALOT N/A
- GNTA N/A
- Revenue
- ALOT $151,283,000.00
- GNTA N/A
- Revenue This Year
- ALOT N/A
- GNTA N/A
- Revenue Next Year
- ALOT N/A
- GNTA N/A
- P/E Ratio
- ALOT N/A
- GNTA N/A
- Revenue Growth
- ALOT 2.16
- GNTA N/A
- 52 Week Low
- ALOT $7.53
- GNTA $2.79
- 52 Week High
- ALOT $18.25
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- ALOT 60.25
- GNTA 59.43
- Support Level
- ALOT $9.07
- GNTA $4.25
- Resistance Level
- ALOT $9.52
- GNTA $5.98
- Average True Range (ATR)
- ALOT 0.40
- GNTA 0.25
- MACD
- ALOT 0.05
- GNTA 0.01
- Stochastic Oscillator
- ALOT 55.32
- GNTA 19.02
About ALOT AstroNova Inc.
AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.